reports
Nature Medicine hebt signifikante Verbesserung der Hand- und Armfunkti...
Nature Medicine hebt signifikante Verbesserung der Hand- und Armfunktion nach einer Rückenmarksverletzung durch die ONWARD® ARC-EX® Therapie hervor ARC Therapy™ hat sich in einer globalen Zulassungsstudie* als sicher und wirksam erwiesen 90 % der Teilnehmer verbesserten entweder die Kraft oder die Funktion der oberen Gliedmaßen* Verbesserung bei Teilnehmern bis zu 34 Jahre nach der Verletzung nachgewiesen* 87 % der Teilnehmer berichteten auch über eine Verbesserung der allgemeinen Lebensqualität* EINDHOVEN, Niederlande, May 21, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: O...
Nature Medicine se réjouit de partager l’amélioration significative de...
Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® Therapy La thérapie ARC Therapy™ s’est révélée sûre et efficace dans le cadre d’une étude pivot mondiale* Quatre-vingt-dix pour cent des participants ont amélioré la force ou la fonction de leurs membres supérieurs* Amélioration démontrée chez les participants jusqu’à 34 ans après la blessure* Quatre-vingt-sept pour cent des participants ont également fait état d’une amélioration de leur qualité de vie globale*...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Padagis LLC and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 17 May 2024 in which Moody's reassessed the appropriateness of the ratings in the context of th...
Solaris Resources Announces $35 Million Common Share Bought Deal Offer...
Solaris Resources Announces $35 Million Common Share Bought Deal Offering NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to announce that it has entered into an agreement with National Bank Financial Markets, RBC Capital Markets, and BMO Capital Markets as bookrunners, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, ...
Solaris Resources Announces $35 Million Common Share Bought Deal Offer...
Solaris Resources Announces $35 Million Common Share Bought Deal Offering VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to announce that it has entered into an agreement with certain underwriters, (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 7,150,000 common shares of the Company (the “Common Shares”) at a price of $4.90 per Common Share (the “Offering Price”), for aggregate gross proceeds of approximately $35,035,000 million (t...
Moody's Ratings upgrades two bonds issued by Shellpoint Co-Originator ...
Moody's Ratings (Moody's) has upgraded the ratings of two bonds issued by Shellpoint Co-Originator Trust 2017-1. The collateral backing this deal consists of prime jumbo mortgage loans. Please click on this link /viewresearchdoc.aspx?docid=PBS_ARFTL490568 for the List of Affe...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of TEAM Services Group, LLC and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 20 May 2024 in which Moody's reassessed the appropriateness of the ratings in the ...
Disclosure of shareholding in IDEX Biometrics - 21 May 2024
Disclosure of shareholding in IDEX Biometrics - 21 May 2024 This notice is issued by IDEX Biometrics ASA on behalf of the shareholder mentioned below. IDEX Biometrics ASA disclosed on 15 May 2024 that it had conducted a private placement of 33.3 million new shares in IDEX Biometrics. Tranche 1 of the private placement amounted to 27.9 million shares. In connection with the private placement, the managers of the private placement, IDEX Biometrics and certain existing shareholders entered into a share lending agreement. Mr. Robert Keith participated in the private placement and subscribed f...
Moody's Ratings assigns a provisional rating to one class of CLO refin...
Moody's Ratings (Moody's) has assigned a provisional rating to one class of CLO refinancing notes (the "Refinancing Notes") to be issued by Dryden 42 Senior Loan Fund (the "Issuer"). Moody's rating action is as follows: U.S.$213,500,000 Class A-1RR Senior Secured Floating Rate Notes due 2036, As...
Moody's Ratings assigns initial Aa2 pledge-specific (GOULT) and GOLT r...
Moody's Ratings (Moody's) has assigned an initial Aa2 GOULT pledge-specific rating (general obligation unlimited tax) to North Central Michigan College District, MI (the College). Moody's has also assigned a Aa2 rating to the college's College Building and Site Bonds, Series 2024 (Limited Tax Genera...
Bavarian Nordic – Transactions in Connection with Share Buy-Back Progr...
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program COPENHAGEN, Denmark, May 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on May 8, 2024, has now been terminated, as the intended number of shares under the program has been repurchased. The program was executed in accordance with the provisions of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and supplementing Regulation (EU) 2016/1052 of 8 Marc...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Nordic Investment Bank and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 16 May 2024 in which Moody's reassessed the appropriateness of the ratings in the co...
LeMaitre to Present at the Jefferies Global Healthcare Conference
LeMaitre to Present at the Jefferies Global Healthcare Conference BURLINGTON, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 11:00 AM ET at the Marriott Marquis in New York City. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and ma...
Alvotech Reports Financial Results for First Quarter of 2024 and Provi...
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update Total revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last year. Gross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last year. Alvotech signed new commercialization agreements for its high concentration interchangeable biosimilar to Humira® in the U.S. and for its proposed biosimilar to Prolia® and Xgeva® in the U.S. and Europe. Alvotech raises topline revenue guidance to $400-$500 million and tightens guidance for b...
Alvotech Reports Financial Results for First Quarter of 2024 and Provi...
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update Total revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last yearGross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last year. Alvotech signed new commercialization agreements for its high concentration interchangeable biosimilar to Humira® in the U.S. and for its proposed biosimilar to Prolia® and Xgeva® in the U.S. and Europe. Alvotech raises topline revenue guidance to $400-$500 million and tightens guidance for bottom...
Moody's Ratings assigns P-1 rating to BMO's CAD1 billion Floating Rate...
Moody's Ratings (Moody's) has today assigned a P-1 rating to Bank of Montreal's (BMO) CAD1 billion Floating Rate Deposit Notes Due April 28 2025 (ISIN A06368LU879). At the same time, Moody's has withdrawn the Aa2 rating previously assigned to these notes, which had a stable outlook. RATINGS RATION...
Moody's Ratings assigns a Ba1 to Cologne Academy, MN's Series 2014A Ch...
Moody's Ratings (Moody's) has assigned a Ba1 rating to Cologne Academy, MN's $13.6 million Charter School Lease Revenue Bonds (Cologne Academy Project), Series 2014A. The bonds were issued through the City of Cologne, MN. Moody's maintains a Ba1 rating on the academy's previously rated debt and the ...
Velcan Holdings: Share buyback program - weekly statement
Velcan Holdings: Share buyback program - weekly statement Luxembourg, 21st May 2024 SHARES REPURCHASE PROGRAMMEAuthorized by the shareholders’ meeting held on 29th June 2021Implemented upon the decision of the Board of Directors dated 2nd January 2024, DISCLOSURE OF PURCHASES EFFECTED FROM 13th MAY 2024 TO 21st MAY 2024 Market: Euro MTF, LuxembourgType of shares: ordinary shares ISIN FR0010245803 Trading date Number of shares purchasedPurchase price per share Total amount of purchases PurposeMarket13/05/20244 10012,49 €51 229.9 €Cancellation or free shares coverageEuro MTF Luxembourg Re...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.